Back
vTv Therapeutics 10K Form
Buy
65
VTVT
vTv Therapeutics
Last Price:
26.00
Seasonality Move:
6.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | VTVT/vTv Therapeutics Quarterly |
| 2023-08-11 | 10Q | VTVT/vTv Therapeutics Quarterly |
| 2023-05-11 | 10Q | VTVT/vTv Therapeutics Quarterly |
| 2022-11-10 | 10Q | VTVT/vTv Therapeutics Quarterly |
| 2022-08-15 | 10Q | VTVT/vTv Therapeutics Quarterly |
| 2022-05-12 | 10Q | VTVT/vTv Therapeutics Quarterly |
Receive VTVT News And Ratings
See the #1 stock for the next 7 days that we like better than VTVT
VTVT Financial Statistics
Sales & Book Value
| Annual Sales: | $2.02M |
|---|---|
| Cash Flow: | $-2.91M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-11.84 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -9.71000 |
|---|---|
| Net Income (TTM): | $-20.25M |
| Gross Margin: | $980K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
vTv Therapeutics Earnings Forecast
Key vTv Therapeutics Financial Ratios
vTv Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VTVT |
| CUSIP: | 918385 |
| Website: | vtvtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VTVT Technical Analysis vs Fundamental Analysis
Buy
65
vTv Therapeutics (VTVT)
is a Buy
Is vTv Therapeutics a Buy or a Sell?
-
vTv Therapeutics stock is rated a Buy
The current vTv Therapeutics [VTVT] share price is $25.50. The Score for VTVT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.